Qivigy (immune globulin intravenous, human-kthm) is a ready-to-use, sterile, non-pyrogenic liquid solution of human immune globulin for IV administration.
The DESTINY-Breast05 trial included patients with HER2-positive primary breast cancer who were at high risk of recurrence and had residual invasive disease in breast or axillary lymph nodes following ...
The approval for plaque PsO was based on data from the PROTOSTAR trial, which evaluated guselkumab in participants aged 6 to 17 years with moderate to severe plaque PsO.
HealthDay News — Acute cystitis may signal the presence of urogenital cancers in middle-aged adults, according to a study published online September 16 in BMJ Public Health.
HealthDay News — A 16-week Mediterranean diet intervention significantly improves psoriasis severity in patients with mild-to-moderate disease receiving stable topical therapy, according to a study ...
HealthDay News — Prevention strategies for cardiovascular manifestations of acute and long COVID are discussed in a report published online September 18 in the European Journal of Preventive ...
HealthDay News — Sprout Organics has widened its recall of 3.5-ounce Sweet Potato, Apple & Spinach pouches because some lots may contain elevated levels of lead. The Food and Drug Administration (FDA) ...
Private equity hospitals reduced ED and ICU salary expenditures after acquisition relative to control hospitals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback